Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Select Medical Holdings (SEM) over the last 17 years, with Q3 2025 value amounting to $247.6 million.

  • Select Medical Holdings' Other Accumulated Expenses fell 3029.61% to $247.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $247.6 million, marking a year-over-year decrease of 3029.61%. This contributed to the annual value of $288.7 million for FY2024, which is 2754.76% up from last year.
  • According to the latest figures from Q3 2025, Select Medical Holdings' Other Accumulated Expenses is $247.6 million, which was down 3029.61% from $286.4 million recorded in Q2 2025.
  • In the past 5 years, Select Medical Holdings' Other Accumulated Expenses ranged from a high of $355.2 million in Q3 2024 and a low of $226.3 million during Q4 2023
  • Moreover, its 5-year median value for Other Accumulated Expenses was $265.5 million (2022), whereas its average is $272.5 million.
  • In the last 5 years, Select Medical Holdings' Other Accumulated Expenses skyrocketed by 3037.42% in 2021 and then crashed by 3029.61% in 2025.
  • Quarter analysis of 5 years shows Select Medical Holdings' Other Accumulated Expenses stood at $244.4 million in 2021, then grew by 8.23% to $264.5 million in 2022, then fell by 14.44% to $226.3 million in 2023, then grew by 27.55% to $288.7 million in 2024, then decreased by 14.24% to $247.6 million in 2025.
  • Its Other Accumulated Expenses stands at $247.6 million for Q3 2025, versus $286.4 million for Q2 2025 and $268.3 million for Q1 2025.